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Intra-peritoneal free elastase in CAPD peritonitis
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Intra-peritoneal free elastase hi CAPD peritonitis. Neutrophil (PMN)
recruitment into the peritoneum during acute bacterial peritonitis is an
important part of the host defense barrier in CAPD patients. However,
the subsequent phagocytosis of bacteria may also lead to PMN degran-
ulation and the release of lysosomal enzymes. We determined the
concentration of neutrophil elastase, both in complex with its natural
inhibitor olPi (EalPi), and in uncomplexed, free form, in infected and
normal CAPD peritoneal fluid by ELISA. In addition elastase activity
was estimated in a casein degradation assay. Infected fluid contained a
median (range) of 1.4 nM (0 to 9.2) free elastase by ELISA and 1.2 nM
(0 to 11.9) activity. There were strong correlations between the perito-
neal leukocyte count and both immunoreactive elastase and activity (r
= 0.816, P < 0.001, 0.687, P < 0.01, respectively). In contrast, normal
fluid contained 0.0 nsi (0 to 0.32) immunoreactive elastase (P < 0.01)
and 0.0 nM (0 to 0.6) elastase activity (P < 0.001). EalPi complexes
were raised significantly during peritonitis at 6.2 nM (0 to 34.3) and were
barely detectable in normal fluid 0.0 nM (0 to 0.17; P < 0.005). The
study shows that small but significant quantities of uninhibited elastase
can be detected in the peritoneal fluid of CAPD patients with acute
bacterial peritonitis. This observation may have important implications
for the pathogenesis of peritoneal membrane damage and the phlogistic
response to infection.
Peritonitis is a serious and common complication of CAPD
which may lead to peritoneal fibrosis and loss of ultrafiltration
[1]. The condition is initially characterized by a rapid influx of
PMN into the peritoneal fluid. The eradication of invading
bacteria by intra-peritoneal phagocytes represents an important
facet of the host defense mechanism. The phagocytosis of
bacteria by PMN, however, may also result in their activation
and subsequent degranulation [2] with the discharge of poten-
tially harmful proteinases such as elastase into the local tissues.
The release of such enzymes is balanced by the presence of
inhibitors such as alpha 1 proteinase inhibitor (alPi). In normal
extracellular sites there is usually an excess of alPi and its rapid
combination with elastase inhibits enzyme activity and limits
tissue damage [31. However, fresh CAPD fluid contains no alPi
and, even after equilibration, levels would only be expected to
reach —5% of plasma levels [4J. This artificial milieu thus
comprises a relatively inhibitor free environment. The present
study estimated intraperitoneal PMN elastase in CAPD patients
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with acute bacterial peritonitis and in normal CAPD fluid by
both immunological and functional assays.
Methods
Patients and sample collection
CAPD fluid samples were collected from patients presenting
with acute peritonitis (N 15) and from non-infected patients(N = 13) who served as controls. All subjects had been
established on CAPD for more than six months. PeritOnitis was
diagnosed on the basis of cloudy bags associated with a raised
peritoneal leukocyte count abdominal discomfort. Fluids
were collected at first presentation of peritonitis, after dwell
times of up to four hours, and cells and debris were removed by
centnfugation within 30 minutes of collection. No patient was
on antibiotics or heparin at presentation. The resultant super-
natants were aliquoted and frozen at —70°C until analysis. A
sample was also sent for routine microscopy and microbiolog-
ical assessment. In addition, samples were obtained from
another 19 patients, after a 12-hour intraperitoneal fluid dwell
time, for estimation of maximal alPi concentration.
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EalPi assay
EalPi levels were determined by a double antibody ELISA
capable of detecting human neutrophil elastase in complex with
alPi [5]. Individual uncomplexed components were not recog-
nized. Briefly, microtiter wells were coated with sheep anti-human
PMN elastase (ICN Biochemicals, Irvine, California, USA) di-
luted 1:1000 in Vollers buffer, incubated overnight at 4°C and
washed. Plasma or peritoneal fluid samples, diluted in buffer
containing 0.1% BSA, were then added to the wells and incubated
for one hour. Rabbit anti-alPi (Calbiochem, San Diego, California
USA) diluted 1:500 in buffer was added and incubated for a further
hour at room temperature. Subsequent washes (x 3) were fol-
lowed by the addition of anti-rabbit IgG conjugated to horse radish
peroxidase (Calbiochem) diluted 1:100 in buffer and the plates
incubated for 60 minutes at room temperature. Substrate chro-
mophore was added for 15 minutes and the reaction stopped by
adding 2 M H2S04. Absorbance was measured at 492 nM on an
automated plate reader. The assay was calibrated using known
concentrations of EalPi complexes formed by adding excess alPi
(Athens Research, Georgia, USA) to pure human neutrophil
elastase. The detection limit was 0.3 nM.
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Table 1. Clinical details of patients presenting with acute bacterial
peritonitis
Patient
Leukocytes
mm3 Organism
EalPi Elastase
nM (ELISA)
Elastase
nM
(activity)
1 710 Staph aureus 0.0 0.0 ND
2 1260 Staph aureus 3.5 1.9 2.2
3 1330 Staph epi 6.2 2.9 0.9
4 240 Pseudomonas 0.0 0.0 0.0
5 2900 Pseudomonas 6.8 2.2 1.4
6 5300 Staph aureus 19.7 6.4 10.2
7 1640 Nil 0.0 0.4 0.6
8 503 Staph epi 0.0 0.0 0.6
9 1100 E faecalis 7.2 1.3 10.0
10 820 Staph aureus 3.5 0.7 6.0
11 9700 Coliforms 34.3 9.2 11.9
12 2030 Staph aureus 9.5 1.4 0.0
13 1520 Staph epi 22.0 3.1 0.0
14 1680 Staph aureus 1.1 0.3 1.1
15 4965 Staph epi 16.4 0.0 ND
Free elastase ELISA
Elastase unbound to alPi was estimated by repeating the EalPi
assay following an initial pre-incubation of each sample with an
excess of alPi (18 p.M) for 60 minutes. In this step free elastase
unbound to alPi is trapped by the exogenous alPi. A difference in
the measured concentration of EalPi as compared to the original
non pre-incubated sample was the estimated free elastase by
ELISA.
Elastase activity assay
Elastase proteolytic activity was determined using azo casein
substrate modified from Barret [6]. Samples were concentrated
tenfold in Centricon 10 tubes (Amicon, USA) at 5000 g. One
hundred microliters of concentrated sample were incubated
with 125 d azocasein (6% wt/vol pH 7.5) and 175 .d sample
buffer (1.25 M Tris, 2.5 M KC1, pH 7.5) and 75 d of either PBS
or alPi (1 mg/mi in PBS). In addition pure neutrophil elastase
standards (0.1 to 100 ng) and negative control incubations of
PBS, both aiPi, were also included. After 24 hours of
incubation at 37°C 1.5 ml of cold 3% trichloracetic acid was
added and the mixtures were filtered through Whatman No. 1
paper. Absorbance at 366 n was measured for each sample
and activity was expressed as equivalents of elastase from the
standard curve obtained with pure elastase samples and cor-
rected for concentration factor.
Assay for intraperitoneal alPi
Concentration of alPi in 16-hour dwell PD samples was deter-
mined by rate nephelometry using a Beckman Array system
(Beckman Instruments Inc., Brea, California USA). This is an
established regional assay in our Protein Reference laboratory.
Statistical analysis
All data are expressed in non-parametric form. Unpaired data
were compared using the Mann Whitney U test to provide z
Infected fluids Normal fluids
Fig. 1. Comparison of elastase concentration by trap ELISA (open
symbols) and activity (closed symbols) in infected and normal CAPD
fluids. * P < 0.05 infected vs. non-infected (Mann Whitney U test), —
= median value.
values, with P derived from the z distribution. Paired data were
evaluated using Wilcoxon's signed rank test. For both tests P <
0.05 was considered to be significant. Correlations between
separate variables were made using linear regression analysis
and expressed as both rand P values; P < 0.05 was significant.
Resutts
Clinical details of all infected patients are outlined in Table 1.
Infected CAPD fluid contained significantly more free elastase
than normal fluid (Fig. 1). Median (range) concentration was 1.4
flM (0 to 9.2) by ELISA (N 15) and 1.2 nM (0 to 11.9) by
activity assay (N = 13). Pentoneal leukocyte count correlated
strongly with both immunoreactive elastase (Fig. 2) and activity
(r = 0.687, P 0.0095). Proteolytic activity in infected fluids
was fully inhibited by 1 mg/mi alPi (Fig. 3). There was a
significant correlation (r = 0.694, P = 0.0085) between ELISA
and activity data (Fig. 4) in infected fluid. In eight patients
EalPi and free elastase were measured both during and six
weeks after recovery from peritonitis. Elevated EalPi and free
elastase were seen in the infected fluid but were both undetect-
able after recovery (data not shown). EalPi complexes were
significantly raised during infection as compared to normal 6.2
nM (0 to 34.3) versus 0 (0 to 0.17; P < 0.005). There were no
concomitant changes in either blood PMN count 5.88 x 109/liter
(4.10 to 8.70) versus 5.05 (4.61 to 7.20), or plasma EalPi
concentration 2.7 nM (1.9 to 4.8) versus 3.1 n (1.8 to 3.7).
The concentration of alPi in equilibrated CAPD fluid was 0.07
mg/mi (<0.03 to 0.12). Reference range in plasma was 1.5 0.5
mg/mi. Median peritoneal/plasma ratio was estimated as 0.05.
Discussion
This present study demonstrates that during acute bacterial
peritonitis in CAPD patients, nanomolar quantities of uninhib-
ited elastase can be detected within the peritoneal cavity by
both a specific immunoassay and an activity assay. The PMN
primary granule enzyme elastase is a powerful serine proteinase
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Abbreviations are: Staph epi, staphylococcus epidermis; Staph au-
reus, staphylococcus aureus; E faecalis, Enterococcus faecalis; ND,
not determined.
Activity
ELISA assay
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Infected Infected fluid
fluid +alPi
Fig. 3. Changes in elastase activity of infected PD fluid before and
after the addition of excess alPi. * P < 0.05 activity without alPi vs.
with alPi (Wilcoxon's signed rank test), r = 0.816, P 0.0002.
which can damage both basement membranes [7] and intact
cells [8]. Histological studies have shown that considerable
damage, including areas of denuda ion, occurs to the mesothe-
hal cell layer during infection [1] and repeated infection can lead
to peritoneal fibrosis, loss of ultrafiltration and, ultimately,
technique failure. In addition elastase can cleave plasma pro-
teins such as complement [8] to form chemotactic factors which
enhance local phagocyte recruitment.
During the phagocytosis of bacteria by PMN, cell activation and
degranulation are known to occur [2]. Under normal circum-
stances extracellular elastase rapidly complexes with the excess of
surrounding inhibitors, of which alPi is the most important [9].
The formation of enzymatically-inactive EalPi complexes thus
limits local proteolytic tissue damage. However, the peritoneal
cavity of CAPD patients comprises an artificial milieu. Fresh
CAPD fluid contains no alPi, and during the course of a 12-hour
dialysis dwell we have shown that it reaches only 5% of plasma
concentration.
In the present study EalPi complexes were detected in n
concentration in infected fluid, indicating the presence of elas-
tase and its subsequent binding to alPi. The elastase is unlikely
to have diffused into the peritoneal cavity from the plasma
compartment, since the plasma levels of EalPi were identical in
both infected and non-infected patients whereas significant
levels of the complex were found only in infected fluids. We
* believe that the elastase is most likely to have arisen from PMN
which invaded the peritoneal cavity during acute bacterial
infection. However, although significant correlations between
PMN numbers and elastase support this hypothesis, the rela-
tively loose fit of the data to linearity (as evidenced by the r
values of <0.83) warrants further comment.
The elastase content of human PMN may vary by up to 300%
[8], and its release during degranulation is dependent upon both
the type and magnitude of cell stimulus [21. Our data represent
analysis of the intra-peritoneal elastase release from 13 patients'
PMN interacting with differing bacterial strains and concentra-
tions. In addition, there is now evidence that peritoneal mesothe-
hal cells can up-regulate the expression of adhesion molecules in
response to inflammatory stimuli [10]. This could lead to adherent
PMN releasing elastase, further increasing errors in simple com-
parisons of elastase versus PMN count. Bearing these potential
sources of error in mind it is not surprising that loose, albeit
significant, fits were seen.
There has been one other report of elevated EalPi complexes
in both plasma and peritoneal fluid during peritonitis which
showed mean intraperitoneal EalPi levels of —40 nM [111.
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Fig. 4. Comparison of elastase activity and immunoreactivity in in-
fected CAPD fluid by linear regression analysis. r = 0.694, P = 0.0085.
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Fig. 2. Correlation between peritoneal leukocyte count (mm3) and
free elastase measured by ELISA in acute peritonitis samples.
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However, our finding of free elastase by both ELISA and
functional assay during infection suggests that this normal inhibi-
tory process is inefficient within the peritoneal cavity during
peritonitis. Reactive oxygen species released by activated PMN
can oxidize critical methionine residues within the elastase binding
site of alPi [8], and although the inhibitor may still be detectable
by immunoassay, its elastase inhibitory capacity may be reduced
by up to 1000-fold [81. A recent study has demonstrated that alPi
in the fluid of patients with peritonitis is oxidized, and that in this
form it is much less efficient at inhibiting elastase mediated
degradation of a chromogenic substrate, and TNFa induced
release of PAF from PMN [12] ex vivo. Our study extends these
observations and confirms that intraperitoneal alPi during perito-
nitis is functionally deficient in vivo.
In conclusion, bacterial peritonitis in CAPD patients leads to
intra-peritoneal elastase release from recruited PMN. The normal
inhibitory processes designed to limit elastase-mediated tissue
damage are locally inefficient, resulting in free elastase activity in
n concentrations. We suggest that this enzyme activity may have
important implications for the pathogenesis of peritoneal mem-
brane damage and the propagation of the inflammatory response
during peritonitis.
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